Eva Winkler

Prof. Eva Winkler is the Managing Director of the National Center for Tumor Diseases (NCT) Heidelberg and holds the Chair of Translational Medical Ethics at Heidelberg University. She leads the Section for Translational Medical Ethics, focusing on ethical challenges in translating research into clinical practice. As a hematologist-oncologist, she also serves as Senior Physician in the Department of Medical Oncology at University Hospital Heidelberg (UKHD). Her roles include Vice-Chair of the German Ethics Council and leadership positions in ZEKO (Center for Ethics in Medicine) and the Association of European Cancer Leagues (AEM).

Her research prioritizes ethical dimensions of genomic technologies, patient data governance, financial toxicity in cancer care, and precision medicine implementation. Notable contributions include frameworks for genomic newborn screening, ethical analysis of clinical trial diversity, and development of patient-reported outcome measures for financial distress.

Recent work addresses challenges in multiprofessional cancer care for young patients, physician-assisted suicide ethics, and economic influences on oncology practice. She actively engages in national and international initiatives to strengthen ethical governance in health research and data sharing, particularly through deliberative forums involving patients and stakeholders.

Awards and honors are not explicitly listed in the provided materials, though her leadership roles reflect significant contributions to medical ethics. Professional activities emphasize balancing clinical practice with advancing equitable, patient-centered healthcare systems through rigorous ethical inquiry.